Procurement Summary
Country : Brazil
Summary : Acquisition of a Tetravalent Inactivated Flu Vaccine.
Deadline : 22 Feb 2024
Other Information
Notice Type : Tender
TOT Ref.No.: 96521778
Document Ref. No. : 90007/2024
Competition : ICB
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : Refer Document
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
Object: Electronic Auction - Acquisition of tetravalent inactivated flu vaccine. 59 Hours
Proposal Delivery: from 02/07/2024 at 08:00
ACQUISITION Tetravalent inactive virus vaccine19981d172c851bd4e8a1788d5726c2d3against influenza with strains provided for in Resolution/ANVISA RDC No. 616 of 2022 (VOTE No. 290/2023/SEI/DIRE2/ANVISA), for the year 2024, packed in glass syringes containing a dose of 0.5ml, with needle standardized by the manufacturer, preserved and ready for use. The composition of the vaccine shouldIt will be compatible for use in children from 6 (six) months of age and in adults of any age. The tetravalent (quadrivalent) vaccine recommended for Brazil in 2024 has the following composition: Influenza 2024 virus strains - A/Victoria/4897/2022 (H1N1)pdm09; - A/Thailand/8/2022 (H3N2); - B/Austria/1359417/2021 (B/Victoria lineage); - B/Phuket/3073/2013 (B/Yamagata lineage). Reference brands: Sanofi Aventis, GSK and Abbott or equivalent.
Quantity: 2600
Documents
Tender Notice